Company Filing History:
Years Active: 2018
Title: Innovator Spotlight: Meital Cohen and Her Contributions to Pharmaceutical Advancements
Introduction: Meital Cohen, a talented inventor based in Pethah-Tikva, Israel, has made significant strides in the pharmaceutical field with her innovative research. With a focus on solid state forms of Ibrutinib, her work exemplifies the intersection of science and technology in developing effective medications.
Latest Patents: Meital Cohen is credited with one notable patent that centers around solid state forms of Ibrutinib. This invention encompasses various solid state forms, specifically forms G, J, and K, along with associated pharmaceutical compositions. The significance of this patent lies in its potential to enhance the efficacy and stability of Ibrutinib, a crucial medication in the treatment of certain cancers.
Career Highlights: Meital Cohen is currently employed at Teva Pharmaceuticals USA, Inc., a leading global pharmaceutical company known for its focus on generic medicines and innovative solutions. During her tenure, she has contributed to various projects that underline her expertise and commitment to advancing healthcare through innovation.
Collaborations: Throughout her career, Meital has collaborated with esteemed colleagues such as Yuval Cohen and Ariel Mittelman. These partnerships have fostered an environment of creativity and innovation, leading to impactful advancements in the pharmaceutical industry.
Conclusion: Meital Cohen’s contributions to the field of pharmaceuticals, particularly with her patented work on solid state forms of Ibrutinib, highlight her role as an inventor dedicated to improving patient outcomes. Her collaborations and career at Teva Pharmaceuticals showcase her commitment to innovation in healthcare, paving the way for future advancements in the industry.